Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Latini

Showing results (151-160 of 157) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 157 results.
European Journal of Pharmacology|December 19, 1996
Mechanism of inhibition of tumor necrosis factor production by chlorpromazine and its derivatives in miceP Ghezzi, S Garattini, T Mennini, et al.
The Canadian Journal of Cardiology|January 28, 1998
Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot StudyR T Tsuyuki, S Yusuf, J L Rouleau, et al.
Circulation|August 10, 2000
PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humansG Peri, M Introna, D Corradi, et al.
European Heart Journal|April 2, 2002
Prediction of 6 months left ventricular dilatation after myocardial infarction in relation to cardiac morbidity and mortality. Application of a new dilatation model to GISSI-3 dataP J de Kam, G L Nicolosi, A A Voors, et al.
Journal of the American College of Cardiology|June 7, 2000
Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative GroupR Latini, G Tognoni, A P Maggioni, et al.
Journal of Internal Medicine|December 17, 2013
The cardiokine secreted Frizzled-related protein 3, a modulator of Wnt signalling, in clinical and experimental heart failureE T Askevold, P Aukrust, S H Nymo, et al.
Vascular Pharmacology|October 3, 2006
Murine models of myocardial and limb ischemia: diagnostic end-points and relevance to clinical problemsP Madeddu, C Emanueli, F Spillmann, et al.
Pageof 16

Showing results (151-160 of 157) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 157 results.
European Journal of Pharmacology|December 19, 1996
Mechanism of inhibition of tumor necrosis factor production by chlorpromazine and its derivatives in miceP Ghezzi, S Garattini, T Mennini, et al.
The Canadian Journal of Cardiology|January 28, 1998
Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot StudyR T Tsuyuki, S Yusuf, J L Rouleau, et al.
Circulation|August 10, 2000
PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humansG Peri, M Introna, D Corradi, et al.
European Heart Journal|April 2, 2002
Prediction of 6 months left ventricular dilatation after myocardial infarction in relation to cardiac morbidity and mortality. Application of a new dilatation model to GISSI-3 dataP J de Kam, G L Nicolosi, A A Voors, et al.
Journal of the American College of Cardiology|June 7, 2000
Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative GroupR Latini, G Tognoni, A P Maggioni, et al.
Journal of Internal Medicine|December 17, 2013
The cardiokine secreted Frizzled-related protein 3, a modulator of Wnt signalling, in clinical and experimental heart failureE T Askevold, P Aukrust, S H Nymo, et al.
Vascular Pharmacology|October 3, 2006
Murine models of myocardial and limb ischemia: diagnostic end-points and relevance to clinical problemsP Madeddu, C Emanueli, F Spillmann, et al.
Pageof 16